Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Ambu A/S
  6. Summary
    AMBU B   DK0060946788

AMBU A/S

(AMBU B)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 01/19 05:06:42 am
138.6 DKK   -0.82%
01/06AMBU A/S : launches aCart™ platform to strengthen single-use endoscopy offering
PU
01/04AMBU A/S : Q1 Aide-mémoire file_download
PU
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P International 700
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
01/13/2022 01/14/2022 01/17/2022 01/18/2022 01/19/2022 Date
150.95(c) 154.95(c) 147.2(c) 139.75(c) 138.85 Last
835 912 823 970 794 682 1 215 926 523 915 Volume
-3.82% +2.65% -5.00% -5.06% -0.64% Change
More quotes
Estimated financial data (e)
Sales 2022 4 744 M 723 M 723 M
Net income 2022 270 M 41,1 M 41,1 M
Net Debt 2022 1 231 M 187 M 187 M
P/E ratio 2022 133x
Yield 2022 0,26%
Sales 2023 5 699 M 868 M 868 M
Net income 2023 534 M 81,4 M 81,4 M
Net Debt 2023 1 324 M 202 M 202 M
P/E ratio 2023 67,1x
Yield 2023 0,47%
Capitalization 35 459 M 5 399 M 5 401 M
EV / Sales 2022 7,73x
EV / Sales 2023 6,45x
Nbr of Employees 4 584
Free-Float 65,8%
More Financials
Company
Ambu A/S is a Denmark-based company engaged in the development, manufacture and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products from resuscitators, face masks and laryngeal masks to the... 
More about the company
Ratings of Ambu A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about AMBU A/S
01/06AMBU A/S : launches aCart™ platform to strengthen single-use endoscopy offering
PU
01/04AMBU A/S : Q1 Aide-mémoire file_download
PU
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P International 700
CI
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P EUROPE 350 - Health Care Equipment & Services (In..
CI
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P EUROPE 350 - Health Care
CI
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P EUROPE 350
CI
01/04AMBU A/S(CPSE : AMBU B) dropped from S&P Global 1200
CI
01/03AMBU A/S : Download the presentation
PU
2021AMBU A/S : Ex-dividend day for final dividend
FA
2021Ambu A/S Announces Board Appointments
CI
2021Ambu A/S Approves Dividend
CI
2021AMBU A/S : Proxy Statments
CO
2021AMBU A/S : Proxy Statments
CO
2021AMBU A/S : awarded single-use endoscopy contract with Vizient Inc. in the USA
PU
2021AMBU A/S : wins Danish Design Award
PU
More news
News in other languages on AMBU A/S
01/05La baisse cherche à emmerder la hausse
2021Recta final antes de 2022
2021Dernière ligne droite avant 2022
2021Ambu A/S approuve un dividende
2021Ambu A/S propose un dividende
More news
Analyst Recommendations on AMBU A/S
More recommendations
Chart AMBU A/S
Duration : Period :
Ambu A/S Technical Analysis Chart | AMBU B | DK0060946788 | MarketScreener
Technical analysis trends AMBU A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 139,75 DKK
Average target price 174,33 DKK
Spread / Average Target 24,7%
EPS Revisions
Managers and Directors
Juan-José Gonzalez Chief Executive Officer
Michael Højgaard CFO, EVP-Global Finance, IT & Investor Relations
Jørgen Jensen Chairman
Måns Eskil Barsne Executive VP-Global Research & Development
Henrik Ankjær Executive Vice President-Global Operations
Sector and Competitors
1st jan.Capi. (M$)
AMBU A/S-19.22%5 399
ABBOTT LABORATORIES-10.07%217 064
MEDTRONIC PLC4.93%144 527
BECTON, DICKINSON AND COMPANY4.43%74 231
HOYA CORPORATION-6.78%51 355
BAXTER INTERNATIONAL INC.0.02%42 990